News items related to: Law and policy reform
-
People’s Resolution: A Roadmap to Protect the Right to Life in a Failed Multilateral Order
We, as members of communities, civil society and activists affected by epidemics, call for a plan of action to end...
-
MMA’s partners in Kazakhstan call for systemic changes to the country’s intellectual property and access to medicines framework in their annual report
Answer Foundation and Antihepatitis C Foundation, MMA’s partners in Kazakhstan, with technical support from ITPC-Ru, recently launched a comprehensive Annual...
-
Brazilian House of Representatives approves bill to suspend patents: finally lives before profits?
Two months ago, the Brazilian Senate approved a law project bill (Law Project 12/21) that allows the country to expand...
-
We can’t end AIDS without tackling patent abuse
Despite significant scientific advancements for HIV, along with global and national commitments to ‘end AIDS’, hundreds of thousands of people...
-
TEDWomen: Why are drug prices so high?
Hear from I-MAK’s Priti Krishtel on how the outdated patent system is the hidden reason that drug prices are so high...
-
The problem with patents: Commitments to HIV and universal health coverage are being undermined in middle-income countries
A joint blog by Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC),...
-
What’s wrong with IP rights? Protecting medicines from competition can be costly
Gram for gram a HIV medicine costs more than gold. What makes drugs so costly? Is it research and development?...
-
Civil society key in TRIPS flexibility implementation
Civil society plays an instrumental role in actively defending access to affordable to medicines, making use of TRIPS flexibilities, and...